These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16465525)

  • 1. [Microarrays for the identification of molecular markers in the diagnosis and therapy of renal cell carcinomas].
    Sültmann H; Poustka A
    Urologe A; 2006 Mar; 45(3):297-8, 300-4. PubMed ID: 16465525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma].
    Merseburger AS; Hennenlotter J; Schilling D; Sievert KD; Küfer R; Kuczyk MA
    Urologe A; 2006 Mar; 45(3):323-4, 326-7. PubMed ID: 16465523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of renal cell carcinoma and clinical implications.
    Rogers CG; Tan MH; Teh BT
    Urology; 2005 Feb; 65(2):231-7. PubMed ID: 15708028
    [No Abstract]   [Full Text] [Related]  

  • 4. [Introduction to the topic: molecular biological elucidation of renal cell carcinoma].
    Küfer R; Hautmann R
    Urologe A; 2006 Mar; 45(3):295-6. PubMed ID: 16482464
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular profiling of renal cancer: the journey to clinical application.
    Ribal MJ
    Eur Urol; 2011 May; 59(5):731-3. PubMed ID: 21296486
    [No Abstract]   [Full Text] [Related]  

  • 6. Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications.
    Li M; Wang Y; Cheng L; Niu W; Zhao G; Raju JK; Huo J; Wu B; Yin B; Song Y; Bu R
    Oncotarget; 2017 Jul; 8(29):48424-48435. PubMed ID: 28467794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics in renal cell carcinoma.
    Dal Cin P
    Curr Opin Urol; 2003 Nov; 13(6):463-6. PubMed ID: 14560139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics.
    Takahashi M; Sugimura J; Yang X; Vogelzang N; Teh BS; Furge K; Teh BT
    Adv Cancer Res; 2003; 89():157-81. PubMed ID: 14587873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of biomarkers and therapeutic targets for renal cell cancer using ProteinChip technology].
    Junker K; von Eggeling F; Müller J; Steiner T; Schubert J
    Urologe A; 2006 Mar; 45(3):305-6, 308, 310-12 passim. PubMed ID: 16491405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
    Slabý O; Svoboda M; Michálek J; Vyzula R
    Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
    Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
    Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival.
    Sültmann H; von Heydebreck A; Huber W; Kuner R; Buness A; Vogt M; Gunawan B; Vingron M; Füzesí L; Poustka A
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):646-55. PubMed ID: 15701852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of renal cell carcinoma.
    Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
    Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
    Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in molecular classification of renal neoplasms.
    Yin-Goen Q; Dale J; Yang WL; Phan J; Moffitt R; Petros JA; Datta MW; Amin MB; Wang MD; Young AN
    Histol Histopathol; 2006 Mar; 21(3):325-39. PubMed ID: 16372253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of genetic markers in the management of kidney cancer.
    Junker K; Ficarra V; Kwon ED; Leibovich BC; Thompson RH; Oosterwijk E
    Eur Urol; 2013 Feb; 63(2):333-40. PubMed ID: 23040205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Papillary renal cell carcinoma and tumor biology. A multicenter project with "tissue microarray" (TMA)].
    Herrmann E; Wülfing C; Hartmann A
    Urologe A; 2007 Sep; 46(9):1175-6. PubMed ID: 17646959
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic factors and molecular markers for renal cell carcinoma.
    Bui MH; Zisman A; Pantuck AJ; Han KR; Wieder J; Belldegrun AS
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):565-75. PubMed ID: 12113089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.